Search - tctmd.com

Displaying 181 - 200 of 203

Sort: Relevancy | Date

News Daily News

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Leah Lawrence

July 11, 2013

Presentation TCT 2013

Randomized comparison of Biolimus-eluting (Nobori) and Everolimus-eluting (Xience/Promus) stents in patients with multivessel coronary artery disease: 12-month follow-up data...

Presenter: Peter Smits, A. J. van Boven, Mariano Valdes, Antonio Serra, Jean-Jacques Goy, V. Voudris, Ramiro Trillo, J. M. Vazquez, Peter den Heijer, Ton Slagboom, A.G. Vuillomenet

January 31, 2013

Presentation TCT 2013

One year clinical outcome of biodegradable and permanent polymer drug-eluting stents for multivessel disease or long lesion (?28mm) in patients with stable and unstable angina

Presenter: Jun-Won Lee, Sung Gyun Ahn, Ji-Hyun Lee, Seung-Hwan Lee, Junghan Yoon, Young-Jin Youn

January 31, 2013

Presentation TCT 2013

Clinical Outcome in Chinese Patients with Long Lesion or Small Vessel / Multivessel Disease Receiving XIENCE V Everolimus-Eluting Stent: Early Results from the SEEDS Study

Presenter: Bo Xu, Yuejin Yang, Yaling Han, Bao Li, Qiang Liu, Guoying Zhu, Junyu Cui, Lang Li, Shuzheng Lu

January 31, 2013

News Daily News

La CABG es Más Rentable a Largo Plazo en Pacientes Diabéticos con Enfermedad Multivaso

Yael L. Maxwell

January 09, 2013

News Daily News

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

Yael L. Maxwell

January 09, 2013

News Daily News

EES Outperform First-Generation DES in Treatment of CTOs

L.A. McKeown

December 27, 2012

Presentation TCT 2012

Multivessel Disease 1: Final Five-Year SYNTAX Results in the MVD Cohort

Presenter: A. Pieter Kappetein

October 22, 2012

News Daily News

Japanese Registry Assesses Stroke Rates for Off- vs. On-pump CABG, PCI

L.A. McKeown

October 09, 2012

News Daily News

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

Yael L. Maxwell

September 07, 2012

News Daily News

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

L.A. McKeown

July 30, 2012

Presentation TCT Russia 2012

DES in Complex Multivessel Disease

Presenter: Gregg W. Stone

May 28, 2012

News Conference News ACC 2012

Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES

Jason Kahn

March 24, 2012

News Daily News

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Jason Kahn

January 08, 2012

News Daily News

Model Tries to Simplify Choice Between Drug-Eluting, Bare-Metal Stents

L.A. McKeown

September 16, 2011

News Daily News

SES Fractures Raise Revascularization Risk, But Not Beyond 1 Year

Caitlin E. Cox

August 05, 2011

News Conference News

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

May 23, 2011

News Conference News

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

April 05, 2011

News Conference News

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Caitlin E. Cox

April 04, 2011

News Conference News

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Jason Kahn

April 04, 2011

Advertisement

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Randomized comparison of Biolimus-eluting (Nobori) and Everolimus-eluting (Xience/Promus) stents in patients with multivessel coronary artery disease: 12-month follow-up data...

One year clinical outcome of biodegradable and permanent polymer drug-eluting stents for multivessel disease or long lesion (?28mm) in patients with stable and unstable angina

Clinical Outcome in Chinese Patients with Long Lesion or Small Vessel / Multivessel Disease Receiving XIENCE V Everolimus-Eluting Stent: Early Results from the SEEDS Study

La CABG es Más Rentable a Largo Plazo en Pacientes Diabéticos con Enfermedad Multivaso

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

EES Outperform First-Generation DES in Treatment of CTOs

Multivessel Disease 1: Final Five-Year SYNTAX Results in the MVD Cohort

Japanese Registry Assesses Stroke Rates for Off- vs. On-pump CABG, PCI

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

DES in Complex Multivessel Disease

Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Model Tries to Simplify Choice Between Drug-Eluting, Bare-Metal Stents

SES Fractures Raise Revascularization Risk, But Not Beyond 1 Year

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content